Joinn Laboratories(China)Co.,Ltd. Stock
Equities
603127
CNE100002W27
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.45 CNY | -3.96% | +6.47% | -26.40% |
Sales 2024 * | 2.35B 326M | Sales 2025 * | 2.8B 388M | Capitalization | 12.04B 1.67B |
---|---|---|---|---|---|
Net income 2024 * | 26M 3.6M | Net income 2025 * | 598M 82.78M | EV / Sales 2024 * | 3.73 x |
Net cash position 2024 * | 3.26B 452M | Net cash position 2025 * | 3.59B 497M | EV / Sales 2025 * | 3.01 x |
P/E ratio 2024 * |
46.9
x | P/E ratio 2025 * |
19.9
x | Employees | 2,510 |
Yield 2024 * |
0.16% | Yield 2025 * |
1.13% | Free-Float | 59.26% |
1 day | -3.96% | ||
1 week | +6.47% | ||
Current month | +6.47% | ||
1 month | -9.11% | ||
3 months | +3.19% | ||
6 months | -38.21% | ||
Current year | -26.40% |
Managers | Title | Age | Since |
---|---|---|---|
Da Peng Gao
CEO | Chief Executive Officer | 42 | 12-10-31 |
Ai Shui Yu
DFI | Director of Finance/CFO | 48 | 19-06-30 |
Ye Li
CHM | Chairman | 42 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yu Xia Feng
FOU | Founder | 60 | 95-08-10 |
Cong Lin Zuo
BRD | Director/Board Member | 60 | 96-11-30 |
Yun Xia Sun
BRD | Director/Board Member | 56 | 99-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.46% | 0 M€ | -12.22% | - | |
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 17.45 | -3.96% | 18,344,700 |
24-05-09 | 18.17 | +0.94% | 19,607,830 |
24-05-08 | 18 | -0.33% | 25,157,640 |
24-05-07 | 18.06 | +0.17% | 33,681,340 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.40% | 1.67B | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 603127 Stock